Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption
- Conditions
- HIV
- Interventions
- Biological: Entyvio (Vedolizumab)
- First Posted Date
- 2016-06-02
- Last Posted Date
- 2020-02-24
- Target Recruit Count
- 26
- Registration Number
- NCT02788175
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults
- Conditions
- Middle East Respiratory Syndrome Coronavirus
- Interventions
- Other: Normal (9%) SalineBiological: SAB-301
- First Posted Date
- 2016-06-02
- Last Posted Date
- 2018-06-12
- Target Recruit Count
- 38
- Registration Number
- NCT02788188
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
PfSPZ Challenge in Non-immune Adults in Baltimore, USA
- Conditions
- Plasmodium Falciparum Infection
- Interventions
- Biological: PfSPZ (7G8) ChallengeBiological: PfSPZ (NF54) Challenge
- First Posted Date
- 2016-05-23
- Last Posted Date
- 2019-01-28
- Target Recruit Count
- 30
- Registration Number
- NCT02780154
- Locations
- 🇺🇸
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States
Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632
- Conditions
- Botulism
- Interventions
- Biological: NTM-1632Other: Placebo
- First Posted Date
- 2016-05-20
- Last Posted Date
- 2018-10-29
- Target Recruit Count
- 24
- Registration Number
- NCT02779140
- Locations
- 🇺🇸
Duke Human Vaccine Institute - Duke Clinical Vaccine Unit, Durham, North Carolina, United States
Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection
- First Posted Date
- 2016-05-19
- Last Posted Date
- 2022-01-04
- Target Recruit Count
- 47
- Registration Number
- NCT02778204
- Locations
- 🇺🇸
Usc La Nichd Crs, Los Angeles, California, United States
🇺🇸St. Jude Children's Research Hospital CRS, Memphis, Tennessee, United States
🇰🇪Kenya Medical Research Institute / Walter Reed Project Clinical Research Center, Kericho CRS, Kericho, Kenya
PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States
- Conditions
- Plasmodium Falciparum Infection
- Interventions
- First Posted Date
- 2016-05-16
- Last Posted Date
- 2019-12-27
- Target Recruit Count
- 28
- Registration Number
- NCT02773979
- Locations
- 🇺🇸
Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases, Seattle, Washington, United States
LACTIN-V Study for Recurrent Bacterial Vaginosis
- Conditions
- Bacterial Vaginosis
- Interventions
- First Posted Date
- 2016-05-09
- Last Posted Date
- 2020-03-04
- Target Recruit Count
- 228
- Registration Number
- NCT02766023
- Locations
- 🇺🇸
University of California, San Diego - Antiviral Research Center, San Diego, California, United States
🇺🇸Washington University School of Medicine in St. Louis - Infectious Disease Clinical Research Unit, Saint Louis, Missouri, United States
🇺🇸Cook County Health and Hospitals System - Ruth M Rothstein CORE Center, Chicago, Illinois, United States
Impact of Allo- and Autoantibodies on Chronic Cardiac Allograft Function
- Conditions
- Pediatric Heart TransplantationPediatric Heart Transplant Recipients
- First Posted Date
- 2016-04-27
- Last Posted Date
- 2019-11-29
- Target Recruit Count
- 407
- Registration Number
- NCT02752789
- Locations
- 🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸Columbia University Medical Center, New York, New York, United States
🇺🇸Children's Hospital Boston, Boston, Massachusetts, United States
A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
- Conditions
- Yellow FeverYellow Fever Immunisation
- Interventions
- Drug: ISA-720Other: PlaceboBiological: MVA Smallpox VaccineBiological: MVA-BN Yellow Fever VaccineBiological: YF Vax 17D Strain
- First Posted Date
- 2016-04-19
- Last Posted Date
- 2023-10-02
- Target Recruit Count
- 92
- Registration Number
- NCT02743455
- Locations
- 🇺🇸
University of Iowa - Vaccine Research and Education Unit, Iowa City, Iowa, United States
🇺🇸Saint Louis University Center for Vaccine Development, Saint Louis, Missouri, United States
A Cohort Study of Operationally Tolerant Allograft Recipients
- Conditions
- Kidney TransplantLiver Transplant
- Interventions
- Procedure: Blood Draw
- First Posted Date
- 2016-04-19
- Last Posted Date
- 2021-09-21
- Target Recruit Count
- 41
- Registration Number
- NCT02743793
- Locations
- 🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸Children's Hospital of Pittsburg of UPMC, Pittsburgh, Pennsylvania, United States
🇺🇸Ann & Robert H. Lurie Children's Memorial Hospital of Chicago, Chicago, Illinois, United States